Cardinal Health's (CAH) stock is trading higher Wednesday after the company beat Wall Street estimates on both revenue and earnings in its latest quarterly results. Fourth-quarter revenue rose 12% year-over-year to $59.87 billion, surpassing the expected $58.54 billion. Adjusted earnings per share also beat projections, coming in at $1.84 compared to the anticipated $1.73.

Cardinal Health Chief Financial Officer Aaron Alt joins Catalysts to discuss the company's outlook.

Alt notes that the results demonstrate ongoing "momentum" at Cardinal Health. He highlights growth in both the pharmacy business and global medical products and distribution segments, citing "a strong pharmaceutical environment" and continued innovation as key factors boosting confidence in their business plan moving forward.

Addressing the partnership with CVS, Alt expresses faith in CVS Health despite its recent underperformance. "I'm never gonna bet against CVS," Alt states, explaining that their collaboration aims to provide customers access to biosimilars "when they need them at the lowest cost."

Regarding inflation, Alt acknowledges it as a headwind the business has faced for several quarters. "It will be with us forever, the only degree is how big it will be," he notes. Alt outlines their strategy of partnering with suppliers and consumers to ensure all parties are "sharing the relative impact of any inflation that comes down the board."

Despite these challenges, he states that Cardinal Health is "confident in the environment" they are operating in.

For more expert insight and the latest market action, click here to watch this full episode of Catalysts.

This post was written by Angel Smith